Boo Edgar
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Pharmacology and Obesity Treatment
- Drug-Induced Hepatotoxicity and Protection
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
Papers in
-
- Gastrointestinal motility and disorders 2
-
- Pharmacology and Obesity Treatment 4
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Ola RönnPer LundborgC G RegårdhPeter H.J.M. DunselmanThomas HednerG. JohnssonL. E. B. JohanssonBertil Abrahamsson
- Journals
- Clinical Pharmacology & Therapeutics (4 papers)Journal of Cardiovascular Pharmacology (2 papers)Clinical Pharmacokinetics (2 papers)Biopharmaceutics & Drug Disposition (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- SwedenNetherlandsCanada
In The Last Decade
Boo Edgar
15 papers receiving 473 citations
Peers
Comparison fields: 5 of 78
- Pharmacology 195
- Pharmaceutical Science 70
- Pharmacology 116
- Analytical Chemistry 66
- Cardiology and Cardiovascular Medicine 129
Countries citing papers authored by Boo Edgar
This map shows the geographic impact of Boo Edgar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boo Edgar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boo Edgar more than expected).
Fields of papers citing papers by Boo Edgar
This network shows the impact of papers produced by Boo Edgar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boo Edgar. The network helps show where Boo Edgar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Boo Edgar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 8 | |
| 2 | Can Innovation Enhance Entrepreneurial Activities of a Region? An Analysis Utilizing the Entrepreneurial Remedy Model (EREM) | 2011 | 0 |
| 3 | Private public partnership and potential conflicts of interest | 2006 | 0 |
| 4 | 1994 | 45 | |
| 5 | 1993 | 14 | |
| 6 | 1992 | 27 | |
| 7 | 1992 | 3 | |
| 8 | 1991 | 96 | |
| 9 | 1991 | 50 | |
| 10 | 1990 | 12 | |
| 11 | 1990 | 2 | |
| 12 | 1990 | 43 | |
| 13 | 1988 | 44 | |
| 14 | 1988 | 16 | |
| 15 | 1987 | 41 | |
| 16 | 1985 | 98 | |
| 17 | 1984 | 9 |
About Boo Edgar
Boo Edgar is a scholar working on Gastroenterology, Pharmacology, Cardiology and Cardiovascular Medicine, Pharmacology and Analytical Chemistry, having authored 17 papers that have together received 508 indexed citations. Recurring topics across this work include Pharmacology and Obesity Treatment (4 papers), Blood Pressure and Hypertension Studies (4 papers), Cardiac electrophysiology and arrhythmias (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Analytical Methods in Pharmaceuticals (3 papers), Gastrointestinal motility and disorders (2 papers), Innovative Microfluidic and Catalytic Techniques Innovation (1 paper) and Garlic and Onion Studies (1 paper). The work is most often cited by research in Pharmacology (195 citations), Pharmaceutical Science (70 citations), Pharmacology (116 citations), Analytical Chemistry (66 citations) and Cardiology and Cardiovascular Medicine (129 citations). Boo Edgar has collaborated with scholars based in Sweden, Netherlands and Canada. Frequent co-authors include Ola Rönn, Per Lundborg, C G Regårdh, Peter H.J.M. Dunselman, Thomas Hedner, G. Johnsson, L. E. B. Johansson, Bertil Abrahamsson, D. D. Breimer and Rik C. Schoemaker. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Journal of Cardiovascular Pharmacology, Clinical Pharmacokinetics, Biopharmaceutics & Drug Disposition and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.